Company registration number 12737271 (England and Wales)
VIOLEGEN LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
VIOLEGEN LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
VIOLEGEN LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
CURRENT ASSETS
Debtors
3
51,392
Cash at bank and in hand
87,715
51,392
87,715
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
4
(1,450)
(37,755)
NET CURRENT ASSETS
49,942
49,960
CAPITAL AND RESERVES
Called up share capital
100,000
100,000
Profit and loss reserves
(50,058)
(50,040)
TOTAL EQUITY
49,942
49,960
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 28 July 2025
Mr Andrew Fry
Director
Company registration number 12737271 (England and Wales)
VIOLEGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
ACCOUNTING POLICIES
Company information
Violegen Limited is a private company limited by shares incorporated in England and Wales. The registered office is Bounty House, Norman Close, Rochester, Kent, ME2 2NF.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Turnover
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
1.3
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2
EMPLOYEES
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
VIOLEGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
3
DEBTORS
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
51,392
4
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
£
£
Trade creditors
15
Amounts owed to group undertakings
37,108
Taxation and social security
(793)
Other creditors
1,450
1,425
1,450
37,755
5
AUDIT REPORT INFORMATION
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Senior Statutory Auditor:
Ataf Salim
Statutory Auditor:
Kilsby & Williams LLP
Date of audit report:
28 July 2025